Find Articles



Return to:Diabetes Articles
Or:Recent Diabetes Articles

Speedel says Novartis' SPP100 drug shows positive results in diabetes ...


http://www.forbes.com/markets/feeds/afx/2007/11/05/afx429...

Forbes - ZURICH (Thomson Financial) - Novartis AG's SPP100 drug has been shown in a phase III clinical trial to further lower excess protein levels in diabetic kidney patients' urine when administered on top of a standard therapy, said Speedel Holding AG ...



Article Finder:

November 05, 2007 12:22:00 AM
Article Directory